Pathophysiology of ischemic acute kidney injury

Research output: Contribution to journalArticle

307 Citations (Scopus)

Abstract

Acute kidney injury (AKI) as a consequence of ischemia is a common clinical event leading to unacceptably high morbidity and mortality, development of chronic kidney disease (CKD), and transition from pre-existing CKD to end-stage renal disease. Data indicate a close interaction between the many cell types involved in the pathophysiology of ischemic AKI, which has critical implications for the treatment of this condition. Inflammation seems to be the common factor that links the various cell types involved in this process. In this Review, we describe the interactions between these cells and their response to injury following ischemia. We relate these events to patients who are at high risk of AKI, and highlight the characteristics that might predispose these patients to injury. We also discuss how therapy targeting specific cell types can minimize the initial and subsequent injury following ischemia, thereby limiting the extent of acute changes and, hopefully, long-term structural and functional alterations to the kidney.

Original languageEnglish
Pages (from-to)189-200
Number of pages12
JournalNature Reviews Nephrology
Volume7
Issue number4
DOIs
StatePublished - Apr 2011

Fingerprint

Acute Kidney Injury
Ischemia
Chronic Renal Insufficiency
Wounds and Injuries
Cell Communication
Chronic Kidney Failure
Inflammation
Morbidity
Kidney
Mortality
Therapeutics

ASJC Scopus subject areas

  • Nephrology

Cite this

Pathophysiology of ischemic acute kidney injury. / Sharfuddin, Asif; Molitoris, Bruce.

In: Nature Reviews Nephrology, Vol. 7, No. 4, 04.2011, p. 189-200.

Research output: Contribution to journalArticle

@article{7566a0eab5294f7f86d9ba1aa0b27ca2,
title = "Pathophysiology of ischemic acute kidney injury",
abstract = "Acute kidney injury (AKI) as a consequence of ischemia is a common clinical event leading to unacceptably high morbidity and mortality, development of chronic kidney disease (CKD), and transition from pre-existing CKD to end-stage renal disease. Data indicate a close interaction between the many cell types involved in the pathophysiology of ischemic AKI, which has critical implications for the treatment of this condition. Inflammation seems to be the common factor that links the various cell types involved in this process. In this Review, we describe the interactions between these cells and their response to injury following ischemia. We relate these events to patients who are at high risk of AKI, and highlight the characteristics that might predispose these patients to injury. We also discuss how therapy targeting specific cell types can minimize the initial and subsequent injury following ischemia, thereby limiting the extent of acute changes and, hopefully, long-term structural and functional alterations to the kidney.",
author = "Asif Sharfuddin and Bruce Molitoris",
year = "2011",
month = "4",
doi = "10.1038/nrneph.2011.16",
language = "English",
volume = "7",
pages = "189--200",
journal = "Nature Reviews Nephrology",
issn = "1759-507X",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Pathophysiology of ischemic acute kidney injury

AU - Sharfuddin, Asif

AU - Molitoris, Bruce

PY - 2011/4

Y1 - 2011/4

N2 - Acute kidney injury (AKI) as a consequence of ischemia is a common clinical event leading to unacceptably high morbidity and mortality, development of chronic kidney disease (CKD), and transition from pre-existing CKD to end-stage renal disease. Data indicate a close interaction between the many cell types involved in the pathophysiology of ischemic AKI, which has critical implications for the treatment of this condition. Inflammation seems to be the common factor that links the various cell types involved in this process. In this Review, we describe the interactions between these cells and their response to injury following ischemia. We relate these events to patients who are at high risk of AKI, and highlight the characteristics that might predispose these patients to injury. We also discuss how therapy targeting specific cell types can minimize the initial and subsequent injury following ischemia, thereby limiting the extent of acute changes and, hopefully, long-term structural and functional alterations to the kidney.

AB - Acute kidney injury (AKI) as a consequence of ischemia is a common clinical event leading to unacceptably high morbidity and mortality, development of chronic kidney disease (CKD), and transition from pre-existing CKD to end-stage renal disease. Data indicate a close interaction between the many cell types involved in the pathophysiology of ischemic AKI, which has critical implications for the treatment of this condition. Inflammation seems to be the common factor that links the various cell types involved in this process. In this Review, we describe the interactions between these cells and their response to injury following ischemia. We relate these events to patients who are at high risk of AKI, and highlight the characteristics that might predispose these patients to injury. We also discuss how therapy targeting specific cell types can minimize the initial and subsequent injury following ischemia, thereby limiting the extent of acute changes and, hopefully, long-term structural and functional alterations to the kidney.

UR - http://www.scopus.com/inward/record.url?scp=79953175649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953175649&partnerID=8YFLogxK

U2 - 10.1038/nrneph.2011.16

DO - 10.1038/nrneph.2011.16

M3 - Article

C2 - 21364518

AN - SCOPUS:79953175649

VL - 7

SP - 189

EP - 200

JO - Nature Reviews Nephrology

JF - Nature Reviews Nephrology

SN - 1759-507X

IS - 4

ER -